The chronic disease management platforms market size has grown rapidly in recent years. It will grow from $8.33 billion in 2025 to $9.56 billion in 2026 at a compound annual growth rate (CAGR) of 14.8%. The growth in the historic period can be attributed to increasing prevalence of chronic diseases globally, growing adoption of telehealth services, growth in healthcare digital infrastructure, increasing demand for continuous patient monitoring, advancements in wearable medical device adoption.
The chronic disease management platforms market size is expected to see rapid growth in the next few years. It will grow to $16.72 billion in 2030 at a compound annual growth rate (CAGR) of 15%. The growth in the forecast period can be attributed to the incorporation of artificial intelligence within clinical decision support systems, the widening adoption of value-driven healthcare models, the expansion of remote patient monitoring initiatives, the rising emphasis on interoperability across healthcare data systems, and the growing uptake of personalized medicine approaches. Major trends in the forecast period include AI-enabled predictive analytics platforms for chronic disease risk assessment, IoT-based remote patient monitoring ecosystems, cloud-supported interoperable electronic health record integration systems, precision medicine-oriented personalized chronic care pathways, and blockchain-powered secure patient data exchange platforms.
The increasing prevalence of lifestyle-related diseases is expected to drive the growth of the chronic disease management platforms market going forward. Lifestyle-related diseases refer to illnesses primarily caused by unhealthy habits and behaviors such as poor diet, physical inactivity, smoking, and excessive alcohol consumption. The rising prevalence of lifestyle-related diseases is attributed to increasing sedentary behavior, as more individuals spend extended hours sitting at desks, using digital devices, and engaging in limited physical activity. Chronic disease management platforms support continuous monitoring, personalized care, medication tracking, and early risk detection to assist in managing lifestyle-related conditions such as diabetes, obesity, hypertension, and cardiovascular diseases. For instance, in June 2024, according to the National Health Service, a UK-based government department, in 2023, the NHS identified over half a million (549,000) additional individuals in England at risk of developing type 2 diabetes, bringing the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330. This represents a significant increase compared to 3,065,825 in 2022, highlighting a rise of nearly 20%. Therefore, the increasing prevalence of lifestyle-related diseases is driving the growth of the chronic disease management platforms market.
Key companies operating in the chronic disease management platforms market are focusing on the development of innovative solutions, such as digital therapeutics and remote patient monitoring platforms, to improve patient engagement, enhance medication adherence, and enable real-time tracking of chronic conditions along with personalized care delivery. Digital therapeutics and remote monitoring platforms are technology-enabled healthcare solutions that integrate connected medical devices, mobile applications, cloud-based analytics, and clinical support systems to remotely monitor and manage chronic diseases, providing a more proactive and data-driven alternative to conventional in-person disease management approaches. For example, in December 2025, the U.S. Food and Drug Administration (US FDA) introduced the Total Product Life Cycle Advisory Program (TAP) Pilot, an initiative aimed at accelerating the development and commercialization of innovative medical devices and digital health technologies, including chronic disease management solutions. The program offers early-stage and strategic regulatory guidance, interactive feedback, and collaborative support to medical device developers across the entire product lifecycle. It is designed to enhance patient access to high-quality digital healthcare technologies by streamlining regulatory pathways and strengthening product safety, effectiveness, and interoperability.
In March 2026, Health Recovery Solutions LLC, a US-based healthcare technology company, acquired Rimidi Inc. for an undisclosed amount. Through this acquisition, Health Recovery Solutions aims to expand and strengthen its remote patient monitoring and chronic disease management capabilities by integrating Rimidi’s EHR-connected clinical workflows, diabetes management solutions, and continuous glucose monitoring (CGM) expertise into its enterprise virtual care platform. Rimidi Inc. is a US-based healthcare technology company specializing in EHR-integrated remote patient monitoring software, chronic disease management solutions, and connected care technologies.
Major companies operating in the chronic disease management platforms market are Oracle Corporation, Koninklijke Philips N.V., Baxter International Inc., Epic Systems Corporation, Teladoc Health Inc., athenahealth Inc., Innovaccer Inc., Amwell, CareCloud Inc., Greenway Health LLC, Arcadia Solutions LLC, DarioHealth Corp., Omada Health Inc., TimeDoc Health LLC, ChartSpan Medical Technologies Inc., Vida Health Inc., HealthSnap Inc., Optimize Health Inc., CareHarmony LLC, Murphi AI Inc., Mahalo Health Inc., KangarooHealth Inc.
North America was the dominant region in the chronic disease management platforms market in 2025. Asia-Pacific is expected to be the rapidly expanding region in the forecast period. The regions covered in chronic disease management platforms report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the chronic disease management platforms market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The chronic disease management platforms market includes revenues earned by entities by providing services such as software-as-a-service (SaaS) platform subscriptions, remote patient monitoring, care coordination and workflow automation, electronic health record (EHR) integration, predictive analytics and clinical decision support, telehealth and virtual care enablement, patient engagement tools, data analytics and reporting, implementation and system integration, customization of digital care pathways, training and support services, and ongoing maintenance and upgrades. The market value includes the value of related goods and embedded digital tools sold by the service provider or included within the platform offering. Only goods and services traded between entities or provided directly to end users are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
The chronic disease management platforms market research report is one of a series of new reports that provides chronic disease management platforms market statistics, including chronic disease management platforms industry global market size, regional shares, competitors with a chronic disease management platforms market share, detailed chronic disease management platforms market segments, market trends and opportunities, and any further data you may need to thrive in the chronic disease management platforms industry. This chronic disease management platforms market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
This product will be delivered within 1-3 business days.
The chronic disease management platforms market size is expected to see rapid growth in the next few years. It will grow to $16.72 billion in 2030 at a compound annual growth rate (CAGR) of 15%. The growth in the forecast period can be attributed to the incorporation of artificial intelligence within clinical decision support systems, the widening adoption of value-driven healthcare models, the expansion of remote patient monitoring initiatives, the rising emphasis on interoperability across healthcare data systems, and the growing uptake of personalized medicine approaches. Major trends in the forecast period include AI-enabled predictive analytics platforms for chronic disease risk assessment, IoT-based remote patient monitoring ecosystems, cloud-supported interoperable electronic health record integration systems, precision medicine-oriented personalized chronic care pathways, and blockchain-powered secure patient data exchange platforms.
The increasing prevalence of lifestyle-related diseases is expected to drive the growth of the chronic disease management platforms market going forward. Lifestyle-related diseases refer to illnesses primarily caused by unhealthy habits and behaviors such as poor diet, physical inactivity, smoking, and excessive alcohol consumption. The rising prevalence of lifestyle-related diseases is attributed to increasing sedentary behavior, as more individuals spend extended hours sitting at desks, using digital devices, and engaging in limited physical activity. Chronic disease management platforms support continuous monitoring, personalized care, medication tracking, and early risk detection to assist in managing lifestyle-related conditions such as diabetes, obesity, hypertension, and cardiovascular diseases. For instance, in June 2024, according to the National Health Service, a UK-based government department, in 2023, the NHS identified over half a million (549,000) additional individuals in England at risk of developing type 2 diabetes, bringing the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330. This represents a significant increase compared to 3,065,825 in 2022, highlighting a rise of nearly 20%. Therefore, the increasing prevalence of lifestyle-related diseases is driving the growth of the chronic disease management platforms market.
Key companies operating in the chronic disease management platforms market are focusing on the development of innovative solutions, such as digital therapeutics and remote patient monitoring platforms, to improve patient engagement, enhance medication adherence, and enable real-time tracking of chronic conditions along with personalized care delivery. Digital therapeutics and remote monitoring platforms are technology-enabled healthcare solutions that integrate connected medical devices, mobile applications, cloud-based analytics, and clinical support systems to remotely monitor and manage chronic diseases, providing a more proactive and data-driven alternative to conventional in-person disease management approaches. For example, in December 2025, the U.S. Food and Drug Administration (US FDA) introduced the Total Product Life Cycle Advisory Program (TAP) Pilot, an initiative aimed at accelerating the development and commercialization of innovative medical devices and digital health technologies, including chronic disease management solutions. The program offers early-stage and strategic regulatory guidance, interactive feedback, and collaborative support to medical device developers across the entire product lifecycle. It is designed to enhance patient access to high-quality digital healthcare technologies by streamlining regulatory pathways and strengthening product safety, effectiveness, and interoperability.
In March 2026, Health Recovery Solutions LLC, a US-based healthcare technology company, acquired Rimidi Inc. for an undisclosed amount. Through this acquisition, Health Recovery Solutions aims to expand and strengthen its remote patient monitoring and chronic disease management capabilities by integrating Rimidi’s EHR-connected clinical workflows, diabetes management solutions, and continuous glucose monitoring (CGM) expertise into its enterprise virtual care platform. Rimidi Inc. is a US-based healthcare technology company specializing in EHR-integrated remote patient monitoring software, chronic disease management solutions, and connected care technologies.
Major companies operating in the chronic disease management platforms market are Oracle Corporation, Koninklijke Philips N.V., Baxter International Inc., Epic Systems Corporation, Teladoc Health Inc., athenahealth Inc., Innovaccer Inc., Amwell, CareCloud Inc., Greenway Health LLC, Arcadia Solutions LLC, DarioHealth Corp., Omada Health Inc., TimeDoc Health LLC, ChartSpan Medical Technologies Inc., Vida Health Inc., HealthSnap Inc., Optimize Health Inc., CareHarmony LLC, Murphi AI Inc., Mahalo Health Inc., KangarooHealth Inc.
North America was the dominant region in the chronic disease management platforms market in 2025. Asia-Pacific is expected to be the rapidly expanding region in the forecast period. The regions covered in chronic disease management platforms report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the chronic disease management platforms market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The chronic disease management platforms market includes revenues earned by entities by providing services such as software-as-a-service (SaaS) platform subscriptions, remote patient monitoring, care coordination and workflow automation, electronic health record (EHR) integration, predictive analytics and clinical decision support, telehealth and virtual care enablement, patient engagement tools, data analytics and reporting, implementation and system integration, customization of digital care pathways, training and support services, and ongoing maintenance and upgrades. The market value includes the value of related goods and embedded digital tools sold by the service provider or included within the platform offering. Only goods and services traded between entities or provided directly to end users are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
The chronic disease management platforms market research report is one of a series of new reports that provides chronic disease management platforms market statistics, including chronic disease management platforms industry global market size, regional shares, competitors with a chronic disease management platforms market share, detailed chronic disease management platforms market segments, market trends and opportunities, and any further data you may need to thrive in the chronic disease management platforms industry. This chronic disease management platforms market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Chronic Disease Management Platforms Market Characteristics
3. Chronic Disease Management Platforms Market Supply Chain Analysis
4. Global Chronic Disease Management Platforms Market Trends And Strategies
5. Chronic Disease Management Platforms Market Analysis Of End Use Industries
7. Global Chronic Disease Management Platforms Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
8. Global Chronic Disease Management Platforms Total Addressable Market (TAM) Analysis for the Market
9. Chronic Disease Management Platforms Market Segmentation
10. Chronic Disease Management Platforms Market, Industry Metrics By Country
11. Chronic Disease Management Platforms Market Regional And Country Analysis
12. Asia-Pacific Chronic Disease Management Platforms Market
13. China Chronic Disease Management Platforms Market
14. India Chronic Disease Management Platforms Market
15. Japan Chronic Disease Management Platforms Market
16. Australia Chronic Disease Management Platforms Market
17. Indonesia Chronic Disease Management Platforms Market
18. South Korea Chronic Disease Management Platforms Market
19. Taiwan Chronic Disease Management Platforms Market
20. South East Asia Chronic Disease Management Platforms Market
21. Western Europe Chronic Disease Management Platforms Market
22. UK Chronic Disease Management Platforms Market
23. Germany Chronic Disease Management Platforms Market
24. France Chronic Disease Management Platforms Market
25. Italy Chronic Disease Management Platforms Market
26. Spain Chronic Disease Management Platforms Market
27. Eastern Europe Chronic Disease Management Platforms Market
28. Russia Chronic Disease Management Platforms Market
29. North America Chronic Disease Management Platforms Market
30. USA Chronic Disease Management Platforms Market
31. Canada Chronic Disease Management Platforms Market
32. South America Chronic Disease Management Platforms Market
33. Brazil Chronic Disease Management Platforms Market
34. Middle East Chronic Disease Management Platforms Market
35. Africa Chronic Disease Management Platforms Market
37. Chronic Disease Management Platforms Market Competitive Landscape And Company Profiles
37. Chronic Disease Management Platforms Market Other Major And Innovative Companies
41. Chronic Disease Management Platforms Market High Potential Countries, Segments and Strategies
42. Appendix
Executive Summary
Chronic Disease Management Platforms Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses chronic disease management platforms market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for chronic disease management platforms? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The chronic disease management platforms market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Solutions; Services2) By Disease Type: Cardiovascular Diseases; Diabetes; Cancer; Respiratory Diseases; Other Disease Types
3) By End User: Healthcare Providers; Healthcare Payers
Subsegments:
1) By Solutions: Population Health Management Solutions; Care Management Solutions; Patient Engagement Solutions; Telehealth Solutions; Remote Patient Monitoring Solutions; Clinical Decision Support Solutions; Healthcare Analytics Solutions2) By Services: Consulting Services; Implementation And Integration Services; Training And Education Services; Support And Maintenance Services; Managed Services
Companies Mentioned: Oracle Corporation; Koninklijke Philips N.V.; Baxter International Inc.; Epic Systems Corporation; Teladoc Health Inc.; athenahealth Inc.; Innovaccer Inc.; Amwell; CareCloud Inc.; Greenway Health LLC; Arcadia Solutions LLC; DarioHealth Corp.; Omada Health Inc.; TimeDoc Health LLC; ChartSpan Medical Technologies Inc.; Vida Health Inc.; HealthSnap Inc.; Optimize Health Inc.; CareHarmony LLC; Murphi AI Inc.; Mahalo Health Inc.; KangarooHealth Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
- Oracle Corporation
- Koninklijke Philips N.V.
- Baxter International Inc.
- Epic Systems Corporation
- Teladoc Health Inc.
- athenahealth Inc.
- Innovaccer Inc.
- Amwell
- CareCloud Inc.
- Greenway Health LLC
- Arcadia Solutions LLC
- DarioHealth Corp.
- Omada Health Inc.
- TimeDoc Health LLC
- ChartSpan Medical Technologies Inc.
- Vida Health Inc.
- HealthSnap Inc.
- Optimize Health Inc.
- CareHarmony LLC
- Murphi AI Inc.
- Mahalo Health Inc.
- KangarooHealth Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | July 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 9.56 Billion |
| Forecasted Market Value ( USD | $ 16.72 Billion |
| Compound Annual Growth Rate | 15.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
